Division of Nephrology and Hypertension, Department of Medicine, University of California San Diego, San Diego VA Healthcare System, San Diego, CA 92161, USA.
Circulation. 2012 May 15;125(19):2316-22. doi: 10.1161/CIRCULATIONAHA.111.072751. Epub 2012 Apr 17.
The liver-secreted protein fetuin-A induces peripheral insulin resistance in vitro. In a pilot study, we observed that higher fetuin-A levels were associated with diabetes mellitus in older persons. However, this finding has not been confirmed in large cohorts. We sought to confirm the association of fetuin-A with incident diabetes mellitus in older persons and to determine whether the association differs by age, sex, and race and among persons with cardiovascular disease (CVD).
Among 3710 community-living individuals ≥ 65 years of age without diabetes mellitus at baseline, fetuin-A was measured in serum collected in 1992 to 1993. Participants were followed up for 10.6 years (median) for incident diabetes mellitus. Cox regression models evaluated the association of fetuin-A with incident diabetes mellitus. Interaction terms evaluated heterogeneity by age, sex, race, and CVD. Mean age was 75 years; 60 were female; 15 were black; and 16 had CVD. Mean fetuin-A concentrations were 0.47 ± 0.10 g/L. During follow-up, 305 incident diabetes cases occurred. Each 0.10-g/L (SD)-greater fetuin-A was associated with 19 higher risk of diabetes mellitus (hazard ratio, 1.19; 95 confidence interval, 1.06-1.33) after adjustment for demographics, lifestyle factors, albumin, kidney function, and CVD. Further adjustment for potential mediators (body mass index, waist circumference, hypertension, lipids, and C-reactive protein) moderately attenuated the association (hazard ratio, 1.13; 95 confidence interval, 1.00-1.28). Results were similar by sex, race, and CVD status but were stronger in persons <75 years old (P for interaction=0.01).
Higher fetuin-A is associated with incident diabetes mellitus in older persons regardless of sex, race, or prevalent CVD status. The association may be attenuated in those ≥ 75 years of age.
肝分泌的胎球蛋白 A 在体外诱导外周胰岛素抵抗。在一项初步研究中,我们观察到,较高的胎球蛋白 A 水平与老年人的糖尿病有关。然而,这一发现尚未在大型队列中得到证实。我们试图证实胎球蛋白 A 与老年人新发糖尿病之间的关联,并确定这种关联是否因年龄、性别和种族以及心血管疾病(CVD)患者而异。
在基线时无糖尿病的 3710 名年龄≥65 岁的社区居住者中,于 1992 年至 1993 年采集血清测量胎球蛋白 A。参与者在随访 10.6 年(中位数)后发生糖尿病。Cox 回归模型评估了胎球蛋白 A 与新发糖尿病之间的关联。交互项评估了年龄、性别、种族和 CVD 之间的异质性。平均年龄为 75 岁;60 名女性;15 名黑人;16 人患有 CVD。平均胎球蛋白 A 浓度为 0.47±0.10g/L。随访期间,发生了 305 例新发糖尿病病例。在调整了人口统计学、生活方式因素、白蛋白、肾功能和 CVD 后,每增加 0.10g/L(标准差)的胎球蛋白 A 与糖尿病风险增加 19%(危险比,1.19;95%置信区间,1.06-1.33)。进一步调整潜在的中介因素(体重指数、腰围、高血压、血脂和 C 反应蛋白)可适度减弱这种关联(危险比,1.13;95%置信区间,1.00-1.28)。结果在性别、种族和 CVD 状态方面相似,但在年龄<75 岁的人群中更强(交互作用 P 值=0.01)。
在老年人中,较高的胎球蛋白 A 与新发糖尿病相关,无论性别、种族或是否存在 CVD。在年龄≥75 岁的人群中,这种关联可能会减弱。